TOP TIERMARKET NEWSWIRE
News & sentiment

ALIGOS THERAPEUTICS Equity (ALGS) — News & AI sentiment

ALIGOS THERAPEUTICS Equity (ALGS) news roundup. 1 story in the past week, 7 over 30 days. Average 30-day sentiment is 52.6/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 58/100
30d stories
7
avg sentiment 52.6/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

ALGS news in the last 24 hours, 7 days, 30 days and 90 days

How much ALGS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowALGS storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days158/100ALGS headlines →
Last 30 days752.6/100ALGS headlines →
Last 90 days1354.2/100ALGS headlines →

Latest stories on ALGS

Nov 6
Nov 6
Nov 6
Nov 6
Nov 6
Nov 5
Nov 5
Oct 5
Oct 5
Sep 15
Sep 2
Sep 2
Why is Aligos Therapeutics stock rallying 7% today?
Investing.com Markets63 · neutralgeneral
Sep 2
Aug 12
H.C. Wainwright reiterates Aligos stock rating on HBV progress
Investing.com Analyst Ratings56 · neutralanalyst
Aug 10
Aug 6
Aligos Therapeutics GAAP EPS of -$0.14
Seeking Alpha34 · bearishearnings
Aug 6
Aug 6
Aug 6
Jul 30
Jul 13
Jul 7
Jul 6
Jul 6
Jun 26
Open ALGS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →